Paying users zone. Data is covered by .

  • Get to Abbott Laboratories for $17.99, or

  • get to whole website for at least 3 months from $49.99.

 

$17.99

Statement of Comprehensive Income

Difficulty: Beginner

Abbott Laboratories, Consolidated Statement of Comprehensive Income

USD $ in millions

 
Source: Abbott Laboratories, Annual Reports
Item Description The company
Foreign currency translation gain (loss) adjustments Adjustment that results from the process of translating subsidiary financial statements and foreign equity investments into functional currency of the reporting entity, net of tax, attributable to the parent entity. Abbott Laboratories's foreign currency translation gain (loss) adjustments increased from 2015 to 2016 and from 2016 to 2017.
Net actuarial gains (losses) and prior service cost and credits and amortization of net actuarial losses and prior service cost and credits, net of taxes Net changes to accumulated comprehensive income during the period related to benefit plans, after tax, attributable to the parent entity. Abbott Laboratories's net actuarial gains (losses) and prior service cost and credits and amortization of net actuarial losses and prior service cost and credits, net of taxes declined from 2015 to 2016 but then slightly increased from 2016 to 2017.
Unrealized gains (losses) on marketable equity securities, net of taxes Gross appreciation or the gross loss in value of the total unsold securities at the end of an accounting period, after tax, attributable to the parent entity.
Net gains (losses) on derivative instruments designated as cash flow hedges, net of taxes Net of tax effect change in accumulated gains and losses from derivative instruments designated and qualifying as the effective portion of cash flow hedges, after taxes, that is attributable to the parent entity. A cash flow hedge is a hedge of the exposure to variability in the cash flows of a recognized asset or liability or a forecasted transaction that is attributable to a particular risk. The change includes an entity's share of an equity investee's increase (decrease) in deferred hedging gains or losses. Abbott Laboratories's net gains (losses) on derivative instruments designated as cash flow hedges, net of taxes increased from 2015 to 2016 but then declined significantly from 2016 to 2017.
Comprehensive income (loss) The change in equity [net assets] of a business enterprise during a period from transactions and other events and circumstances from non-owner sources which are attributable to the reporting entity. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners, but excludes any and all transactions which are directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent. Abbott Laboratories's comprehensive income (loss) declined from 2015 to 2016 but then slightly increased from 2016 to 2017.

Top